CoreCap Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CoreCap Advisors's LLY Position: Q2 2026 in Review
CoreCap Advisors increased its Eli Lilly (LLY) stake by 8.3% in Q2 2026, buying an estimated $299K and bringing the position to 3,816 shares worth $4.58M. The position accounts for 0.13% of the portfolio, ranked #161.
CoreCap Advisors first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $5.67M in Q3 2024. 1,325 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- CoreCap Advisors held 3,816 shares of Eli Lilly worth $4.58M as of Q2 2026.
- CoreCap Advisors bought 293 Eli Lilly shares in Q2 2026, an estimated $299K.
- Eli Lilly made up 0.13% of CoreCap Advisors's portfolio in Q2 2026, its #161 holding.
- CoreCap Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
- CoreCap Advisors's Eli Lilly position peaked at $5.67M in Q3 2024.
- 1,325 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.